Neuroendocrine Tumor Grade 2 Clinical Trials

8 clinical trials for Neuroendocrine Tumor Grade 2 across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CapTemY90 for Grade 2/3 NET Liver Metastases — RECRUITING · PHASE2
• 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry — RECRUITING · PHASE2
• Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN) — RECRUITING
• Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial — RECRUITING · PHASE2
• Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors — RECRUITING · PHASE2
• Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases — TERMINATED · PHASE2
• A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search